Regulation of the hypoxanthine phosphoribosyltransferase gene: In vitro and in vivo approaches

Proceedings of the Society for Experimental Biology and Medicine

Volumn 212, Issue 2, 1996, Pages 116-127

  Jiralerspong, Sarn ^a   Patel, Pragna I ^a  

^a BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; TRANSCRIPTION FACTOR AP 2; TRANSCRIPTION FACTOR SP1;

CHROMOSOME INACTIVATION; DNA FOOTPRINTING; DNA METHYLATION; GENE DELETION; GENE EXPRESSION REGULATION; GENE LOCUS; GENE THERAPY; HOUSEKEEPING GENE; HUMAN; LESCH NYHAN SYNDROME; NONHUMAN; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; PURINE METABOLISM; REPRESSOR GENE; SHORT SURVEY; TRANSCRIPTION REGULATION; TRANSGENIC MOUSE; X CHROMOSOME RECESSIVE DISORDER;

EID: 0029950881     PISSN: 00379727     EISSN: None     Source Type: Journal    
DOI: 10.3181/00379727-212-43998     Document Type: Short Survey

References (141)

1. Valerio D, Duyvesteyn MG, Dekker BM, Weeda G, Berkvens TM, van der Voorn L, van Ormondt H, van der Eb AJ. Adenosine deaminase: Characterization and expression of a gene with a remarkable promoter. EMBO J 4:437-443, 1985.
2. Chen MJ, Shimada T, Moulton AD, Cline A, Humphries RK, Maizel J, Nienhuis AW. The functional human dihydrofolate reductase gene. J Biol Chem 259:3933-3943, 1984.
3. Yang JK, Masters JN, Attardi G. Human dihydrofolate reductase gene organization. Extensive conservation of the G + C-rich 5′ non-coding sequence and strong intron size divergence from homologous mammalian genes. J Mol Biol 176:169-187, 1984.
4. Crouse GF, Leys EJ, McEwan RN, Frayne EG, Kellems RE. Analysis of the mouse DHFR promoter region: Existence of a divergently transcribed gene. Mol Cell Biol 5:1847-1858, 1985.
5. McGrogan M, Simonsen CC, Smouse DT, Farnham PJ, Schimke RT. Heterogeneity at the 5' termini of mouse dihydrofolate reductase mRNAs. Evidence for multiple promoter regions. J Biol Chem 260:2307-2314, 1985.
6. Singer-Sam J, Keith DH, Tani K, Simmer RL, Shively L, Lindsay S, Yoshida A, Riggs AD. Sequence of the promoter region of the gene for human X-linked 3-phosphoglycerate kinase. Gene 32:409-417, 1984.
7. Dynan WS. Promoters for housekeeping genes. Trends Genet 2:196-197, 1986.
8. Melton DW. Strategies and mechanisms for the control of transcriptional initiation of mammalian protein-coding genes. J Cell Sci 88:267-270, 1987.
9. Seegmiller JE, Rosenbloom FM, Kelley WN. Enzyme defect associated with a sex-linked human neurological disorder and excessive purine synthesis. Science 155:1682-1684, 1967.
10. Nyhan WL. The Lesch-Nyhan syndrome. Annu Rev Med 24:41-60, 1973.
11. Emmerson BT, Thompson L. The spectrum of hypoxanthine-guanine phosphoribosyltransferase deficiency. Q J Med 166:423-440, 1973.
12. Watts RWE, Spellacy E, Gibbs DA, Allsop J, McKeran RO, Slavin GE. Clinical, post-mortem, biochemical and therapeutic observations on the Lesch-Nyhan syndrome with particular reference to the neurological manifestations. Q J Med 201:43-78, 1982.
13. Maniatis T, Goodbourn S, Fischer JA. Regulation of inducible and tissue-specific gene expression. Science 236:1237-1245, 1987.
14. Kelley WN, Rosenbloom FM, Henderson JF, Seegmiller JE. A specific enzyme defect in gout associated with overproduction of uric acid. Proc Natl Acad Sci USA 57:1735-1739, 1967.
15. Yu TF, Balis ME, Krenitsky TA, Dancis J, Silvers DN, Elion GB, Gutman AB. Rarity of X-linked partial hypoxanthine-guanine phosphoribosyltransferase deficiency in a large gouty population. Ann Intern Med 76:255-264, 1972.
16. Kelley WN, Greene ML, Rosenbloom FM, Henderson JF, Seegmiller JE. Hypoxanthine-guanine phosphoribosyltransferase deficiency in gout. Ann Intern Med 70:155-206, 1969.
17. Seegmiller JE. Diseases of purine and pyrimidine metabolism. In: Bondy PK, Rosenberg LE, Eds. Metabolic Control and Disease (8th ed). Philadelphia: W. B. Saunders, pp777-937, 1980.
18. Murray AW, Elliott DC, Atkinson MR. Nucleotide biosynthesis from performed purines in mammalian cells: Regulatory mechanisms and biological significance. Prog Nucleic Acid Res Mol Biol 10:87-119, 1970.
19. Murray AW. The biological significance of purine salvage. Annu Rev Biochem 40:811-826, 1971.
20. Henderson JF, Paterson ARP. Nucleotide Metabolism: An Introduction. New York: Academic Press, pp124-135, 1973.
21. Puig JG, Jimenez MJ, Mateos FA, Fox IH. Adenine nucleotide turnover in hypoxanthine-guanine phosphoribosyltransferase deficiency: Evidence for an increased contribution of purine byosinthesis de novo. Metabolism 38:410-418, 1989.
22. Hoefnagel D, Andrew ED, Mireault NG, Berndt WO. Hereditary choreoathetosis, self-mutilation and hyperuricemia in young males. N Engl J Med 273:130-135, 1965.
23. Shapiro SL, Sheppard GL Jr., Dreifuss FE, Newcombe DS. X-linked recessive inheritance of a syndrome of mental retardation with hyperuricemia. Proc Soc Exp Biol Med 122:609-611, 1966.
24. Nyhan WL, Pesek J, Sweetman L, Carpenter DG, Carter CH. Genetics of an X-linked disorder of uric acid metabolism and cerebral function. Pediatr Res 1:5-13, 1967.
25. Crawhall JC, Henderson JF, Kelley WN. Diagnosis and treatment of the Lesch-Nyhan syndrome. Pediatr Res 6:504-513, 1972.
26. Lesch M, Nyhan WL. A familial disorder of uric acid metabolism and central nervous system dysfunction. Am J Med 36:561-570, 1964.
27. Rosenbloom FM, Henderson JF, Caldwell IC, Kelley WN, Seegmiller JE. Biochemical basis of accelerated purine synthesis de novo in human fibroblasts lacking hypoxanthine-gluanine phosphoribosyltransferase. J Biol Chem 243:1166-1177, 1968.
28. Skaper SD, Seegmiller JE. Hypoxanthine-guanine phosphoribosyltransferase mutant glioma cells: Diminished monamine oxidase activity. Science 194:1171-1173, 1976.
29. Lloyd KG, Hornykiewicz O, Davidson L, Shannak K, Farley I, Goldstein M, Shibuya M, Kelley WN, Fox HI. Biochemical evidence of dysfunction of brain neurotransmitters in the Lesch-Nyhan syndrome. N Engl J Med 5:1106-1111, 1981.
30. Silverstein FS, Johnston MV, Hutchinson RJ, Edwards NL. Lesch-Nyhan syndrome: CSF neurotransmitter abnormalities. Neurology 35:907-911, 1985.
31. Jankovic J, Caskey TC, Stout JT, Butler IJ. Lesch-Nyhan syndrome: A study of motor behavior and cerebrospinal fluid neurotransmitters. Ann Neurol 23:466-469, 1988.
32. Balis ME, Krakoff IH, Berman PH, Dancis J. Urinary metabolites in congenital hyperuricosuria. Science 156:1122-1123, 1967.
33. Balis ME. Seminars on Lesch-Nyhan syndrome. Aspects of purine metabolism. Fed Proc 27:1067-1074, 1968.
34. Wyngaarden JB, Ashton DM. The regulation of activity of phosphoribosylepryophosphate amidotransferase by purine ribonucleotides: A potential feedback control of purine biosynthesis. J Biol Chem 234:1492-1496, 1959.
35. Udom A, Holmes EW. Purification and characterization of human amidophosphoribosyltransferase. J Clin Chem Clin Biochem 20:428, 1982.
36. Jinnah HA, Page T, Friedman T. Brain purities in a genetic mouse model of Lesch-Nyhan disease. J Neurochem 60:2036-2045, 1993.
37. Jinnah HA, Wojcik BE, Hunt M, Narang N, Lee KY, Goldstein M, Wamsley JK, Langlais PJ, Friedmann T. Dopamine deficiency in a genetic mouse model of Lesch-Nyhan disease. J Neurosci 14:1164-1175, 1994.
38. Baumeister AA, Frye GD. The biochemical basis of the behavioral disorder in the Lesch-Nyhan syndrome. Neurosci Biobehav Rev 9:169-178, 1985.
39. Alpin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends Neurosci 12:366-375, 1987.
40. Stout JT, Caskey CT. Hypoxanthine phosphoribosyltransferase deficiency: The Lesch-Nyhan syndrome and gouty arthritis. In: Scriver CR, Beaudet AL, Sly WS, Valle D. Eds. The Metabolic Basis of Inherited Disease (6th ed). New York: McGraw-Hill, pp1007-1028, 1989.
41. Kelley WN. Hypoxanthine-guanine phosphoribosyltransferase deficiency in the Lesch-Nyhan syndrome and gout. Fed Proc 27:1047-1052, 1968.
42. Rossiter BJF, Caskey CT. Hypoxanthine-guanine phosphoribosyltransferase deficiency: Lesch-Nyhan syndrome and gout. In: Scriver CR, Beaudet AL, Sly WS, Valle D, Eds. The Metabolic and Molecular Bases of Inherited Disease (7th ed). New York: McGraw-Hill, pp1679-1706, 1995.
43. Cariello NF, Skopek TR. In vivo mutation at the human HPRT locus. Trends Genet 9:322-326, 1993.
44. Sculley DG, Dawson PA, Emmerson BT, Gordon RB. A review of the molecular basis of hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency. Hum Genet 90:195-207, 1992.
45. Fujimori S, Tagaya T, Kamatani N, Akaoka I. A germ line mutation within the coding sequence for the putative 5-phosphoribosyl-1-pyrophosphate binding site of hypoxanthine-guanine phosphoribosyltransferase (HPRT) in a Lesch-Nyhan patient: Missense mutations within a functionally important region probably cause disease. Hum Genet 90:385-388, 1992.
46. Yamada Y, Goto H, Suzumori K, Adachi R, Ogasawara N. Molecular analysis of five independent Japanese mutant genes responsible for hypoxanthine guanine phosphoribosyltransferase (HPRT) deficiency. Hum Genet 90:379-384, 1992.
47. Madrid) in exon 3 of the human hypoxanthine-guanine phosphoribosyltransferase (HPRT) gene. Hum Genet 91:451-454, 1993.
48. Marcus S, Christensen E, Malm G. Molecular analysis of the mutations in five unrelated patients with the Lesch-Nyhan syndrome. Hum Mutat 24:473-477, 1993.
49. Tohyama J, Nanba E, Ohno K. Hypoxanthine-guanine phosphoribosyltransferase (HPRT) deficiency: Identification of point mutations in Japanese patients with Lesch-Nyhan syndrome and hereditary gout and their permanent expression in an HPRT-deficient mouse cell line. Hum Genet 93:175-181, 1994.
50. Marcus S, Steen AM, Andersson B, Lambert B, Kristoffersson U, Francke U. Mutation analysis and prenatal diagnosis in a Lesch-Nyhan family showing non-random X-inactivation interfering with carrier detection tests. Hum Genet 89:395-100, 1992.
51. Sege-Peterson K, Chambers J, Page T, Jones OW, Nyhan WL. Characterization of mutations in phenotypic variants of hypoxanthine phosphoribosyltransferase deficiency. Hum Mol Genet 1:427-432, 1992.
52. Keio). Jpn J Hum Genet 38:413-419, 1993.
53. Fuscoe JC, Nelsen AJ. Molecular description of a hypoxanthine phosphoribosyltransferase gene deletion in Lesch-Nyhan syndrome. Hum Mol Genet 3:199-200, 1994.
54. Marcus S, Hellgren D, Lambert B, Fallstrom SP, Wahlstrom J. Duplication in the hypoxanthine phosphoribosyl-transferase gene caused by Alu-Alu recombination in a patient with Lesch-Nyhan syndrome. Hum Genet 90:477-482, 1993.
55. Haldane JBS. The rate of spontaneous mutation of a human gene. J Genet 31:317, 1935.
56. Francke U, Winter RM, Lin D, Bakay B, Seegmiller JE, Nyhan WL. Use of carrier detection tests to estimate male to female ratio of mutation rates in Lesch-Nyhan disease. In: Hook EB, Porter IH, Eds. Population and Biological Aspects of Human Mutation. New York: Academic Press, pp117-130, 1981.
57. Hara K, Kashiwamata S, Ogasawara N, Ohishi H, Natsume R, Yamanaka T, Hakamada S, Miyazaki S, Watanabe K. A female case of the Lesch-Nyhan syndrome. Tohoku J Exp Med 137:275-282, 1982.
58. Ogasawara N, Stout JT, Goto H, Sonta S, Matsumoto A, Caskey CT. Molecular analysis of a female Lesch-Nyhan patient. J Clin Invest 84:1024-1027, 1989.
59. Ogasawara N, Yamada Y, Goto H. HPRT gene mutations in a female Lesch-Nyhan patient. Adv Exp Med Biol 309B:109-112, 1991.
60. Wilson JM, Tarr GE, Mahoney WC, Kelly WN. Human hypoxanthine-guanine phosphoribosyltransferase. Complete amino acid sequence of the erythrocyte enzyme. J Biol Chem 257:10978-10985, 1982.
61. Konecki DS, Brennand J, Fuscoe JC, Caskey CT, Chinault AC. Hypoxanthine-guanine phosphoribosyltransferase genes of mouse and Chinese hamster: Construction and sequence analysis of cDNA recombinants. Nucleic Acids Res 10:6763-6775, 1982.
62. Yang TP, Patel PI, Chinault AC, Stout JT, Jackson LG, Hildebrand BM, Caskey CT. Molecular evidence of new mutation at the HPRTlocus in Lesch-Nyhan patients. Nature 310:412-414, 1984.
63. Rossiter BJF, Caskey CTC. Molecular scanning methods of mutation detection. J Biol Chem 265:12753-12756, 1990.
64. Chiaverotti TA, Battula N, Monnat RJ Jr. Rat hypoxanthine phosphoribosyltransferase cDNA cloning and sequence analysis. Adv Exp Med Biol 309B:117-120, 1991.
65. Rosenbloom FM, Kelley WN, Miller J, Henderson JF, Seegmiller JE. Inherited disorder of purine metabolism. JAMA 202:103-105, 1967.
66. Adams A, Harkness RA. Developmental changes in purine phosphoribosyltransferases in human and rat tissues. Biochem J 160:565-576, 1976.
67. Krenitsky TA. Tissue distribution of purine ribosyl- and phosphoribosyltransferases in the Rhesus monkey. Biochim Biophys Acta 179:506-509, 1969.
68. Murray AW. Inhibition of purine phosphoribosyltransferases from Ehrlich ascites-tumor cells by purine nucleotides. Biochem J 100:671-674, 1966.
69. Lo YV, Palmour RM. Developmental expression of murine HPRT. I. Activities, heat stabilities, and electrophoretic mobilities in adult tissues. Biochem Genet 17:737-746, 1979.
70. Steen AM, Luthman H, Hellgren D, Lambert B. Levels of hypoxanthine phosphoribosyltransferase RNA in human cells. Exp Cell Res 186:236-244, 1990.
71. Lajtha LG, Vane JR. Dependence of bone marrow cells on the liver for purine supply. Nature 182:191-192, 1958.
72. Lowy BA, Ramot B, London JM. The biosynthesis of adenosine triphosphate and guanosine triphosphate in the rabbit erythrocyte in vivo and in vitro. J Biol Chem 235:2920-2923, 1960.
73. Holmsen H, Rozenberg MC. Adenine nucleotide metabolism of blood platelets. 3. Adenine phosphoribosyl transferase and nucleotide formation from exogenous adenine. Biochem Biophys Acta 157:266-279, 1968.
74. Fontenelle LJ, Henderson JF. An enzymatic basis for the inability of erythrocytes to synthesize purine ribonucleotides de novo. Biochim Biophys Acta 177:175-176, 1969.
75. Howard WJ, Kerson LA, Appel SH. Synthesis do novo of purines in slices of rat brain and liver. J Neurochem 17:121-123, 1970.
76. Allsop J, Watts RW. Activities of amidophosphoribosyltransferase (ec2.4.2.14) and the purine phosphoribosyltransferases (ec2.4.2.7 and 2.4.2.8), and the phosphoribosylpyrophosphate content of rat central nervous system at different stages of development. Their possible relationship to the neurological dysfunction in the Lesch-Nyhan syndrome. J Neurol Sci 46:221-232, 1980.
77. Rincon-Limas DE, Geske RS, Xue J-J, Hsu CY, Overbeek PA, Patel PI. 5′-Flanking sequences of the human HPRT gene direct neuronal expression in the brain of transgenic mice. J Neurosci Res 38:259-267, 1994.
78. Jinnah HA, Hess EJ, Wilson MC, Gage FH, Friedmann T. Localization of hypoxanthine-guanine phosphoribosyltransferase mRNA in the mouse brain by in situ hybridization. Mol Cell Neurosci 3:64-78, 1992.
79. Gutensohn W, Guroff G. Hypoxanthine-guanine-phosphoribosyl-transferase from rat brain (purification, kinetic properties, development and distribution). J Neurochem 19:2139-2150, 1972.
80. Finger S, Heavens RP, Sirinathsinghji DJ, Kuhen MR, Dunnet SB. Behavioral and neurochemical evaluation of a transgenic mouse model of Lesch-Nyhan syndrome. J Neurol Sci 86:203-213, 1988.
81. -) mouse model of Lesch-Nyhan syndrome. Brain Res 501:401-406, 1989.
82. - mice. Adv Exp Med Biol 3098:269-272, 1991.
83. Shows TB, Brown JA. Localization of genes coding for PGK, HPRT, and G6PD on the long arm of the X chromosome in somatic cell hybrids. Cytogenet Cell Genet 14:426-429, 1975.
84. Farrell SA, Worton RG. Chromosome loss is responsible for segregation at the HPRTlocus in Chinese hamster cell hybrids. Somatic Cell Genet 3:359-551, 1977.
85. Fenwick RG, Jr. Reversion of a mutation affecting the molecular weight of HGPRT: Intragenic suppression and localization of X-linked genes. Somatic Cell Genet 6:477-494, 1980.
86. Francke U, Taggart RT. Comparative gene mapping: Order of loci on the X chromosome is different in mice and humans. Proc Natl Acad Sci USA 77:3595-3599, 1980.
87. Pai GS, Sprenkle JA, Do TT, Mareni CE, Migeon BR. Localization of loci for hypoxanthine phosphoribosyltransferase and glucose-6-phosphate dehydrogenase and biochemical evidence of nonrandom X chromosome expression from studies of a human X-autosome translocation. Proc Natl Acad Sci USA 77:2810-2813, 1980.
88. Lyon MF, Zenthon J, Burtenshaw MD, Evans EP. Localization of the HPR T locus by in situ hybridization and distribution of loci on the mouse X-chromosome. Cytogenet Cell Genet 44:163-166, 1987.
89. Patel PI, Nussbaum RL, Framson PE, Ledbetter DH, Caskey CT, Chinault AC. Organization of the HPRT gene and related sequences in the human genome. Somat Cell Mol Genet 10:483-493, 1984.
90. Isamat M, Macleod KF, King A, McEwan C, Melton DW. Characterization, evolutionary relationships, and chromosome location of processed mouse HPRT pseudogene. Somat Cell Mol Genet 14:359-369, 1988.
91. Edwards A, Voss H, Rice P, Civitello A, Stegemamm J, Schwager C, Zimmermann J, Erfle H, Caskey CT, Ansorge W. Automated DNA sequencing of the human HPRT locus. Genomics 6:593-608, 1990.
92. Rossiter BJ, Fuscoe JC, Muzny DM, Fox M, Caskey CT. The Chinese hamster HPRT gene: Restriction map, sequence analysis, and multiplex PCR deletion screen. Genomics 9:247-256, 1991.
93. Melton DW, Konecki DS, Brennand J, Caskey CT. Structure, expression, and mutation of the hypoxanthine phosphoribosyltransferase gene. Proc Natl Acad Sci USA 81:2147-2151, 1984.
94. Kim SH, Moores JC, David D, Respess JG, Jolly DJ, Friedmann T. The organization of the human HPRT gene. Nucleic Acids Res 14:3103-3118, 1986.
95. Patel PI, Framson PE, Caskey CT, Chinault AC. Fine structure of the human hypoxanthine phosphoribosyltransferase gene. Mol Cell Biol 6:393-403, 1986.
96. Elder JT, Spritz RA, Weissman SM. Simian virus 40 as a eukaryotic cloning vehicle. Annu Rev Genet 15:295-340, 1981.
97. Hansen U, Sharp PA. Sequences controlling in vitro transcription of SV40 promoters. EMBO J 2:2293-2303, 1983.
98. Breathnach R, Chambon P. Organization and expression of eucaryotic split genes coding for proteins. Annu Rev Biochem 50:349-383, 1981.
99. Kadonaga JT, Jones KA, Tijian R, Promoter-specific activation of RNA polymerase II transcription of Sp1. Trends Biochem Sci 11:20-23, 1986.
100. Melton DW, McEwan C, McKie AB, Reid AM. Expression of the mouse HPRT gene: Deletional analysis of the promoter region of an X-chromosome linked housekeeping gene. Cell 44:319-328, 1986.
101. Mohandas T, Sparkes RS, Shapiro LJ. Reactivation of an inactive human X chromosome: Evidence for X inactivation by DNA methylation. Science 211:393-396, 1981.
102. Graves JAM. 5-azacytidine-induced re-expression of alleles on the inactive X chromosome in a hybrid mouse cell line. Exp Cell Res 141:99-105, 1982.
103. Hors-Cayala MC, Heuertz S, Frezal J. Coreactivation of four inactive X genes in a hamster x human hybrid and persistence of late replication of reactivated X chromosome. Somatic Cell Genet 9:645-657, 1983.
104. Paterno GD, Adra CN, McBurney MW. X chromosome reactivation in mouse embryonal carcinoma cells. Mol Cell Biol 5:2705-2712, 1985.
105. Lock LF, Melton DW, Caskey CT, Martin GR. Methylation of the mouse HPRT gene differs on the active and inactive X chromosomes. Mol Cell Biol 6:914-924, 1986.
106. Hornstra IK, Yang TP. High-resolution methylation analysis of the human hypoxanthine phosphoribosyltransferase gene 5′ region on the active an inactive X chromosomes: Correlation with binding sites for transcription factors. Mol Cell Biol 14:1419-1430, 1994.
107. Park JG, Chapman VM. CpG island promoter region methylation patterns of the inactive-X-chromosome hypoxanthine phosphoribosyltransferase (HPRT) gene. Mol Cell Biol 14:7975-7983, 1994.
108. Brandeis M, Frank D, Keshet I, Siegfried Z, Mendelsohn M, Nemes A, Temper V, Razin A, Cedar H. Sp1 elements protect a CpG island from de novo methylation. Nature 371:435-438, 1994.
109. Macleod D, Charlton J, Mullins J, Bird AP. Sp1 sites in the mouse APRT gene promoter are required to prevent methylation of the CpG island. Genes Dev 8:2282-2292, 1994.
110. Harrington MA, Jones PA, Imagawa M, Karin M. Cytosine methylation does not affect binding of transcription factor Sp1. Proc Natl Acad Sci USA 85:2066-2270, 1988.
111. Holler M, Westin G, Jiricny J, Schaffner W. Sp1 transcription factor binds DNA and activates transcription even when the binding site is CpG methylated. Genes Dev 2:1127-1135, 1988.
112. Jane SM, Gumucio DL, Ney PA, Cunningham JM, Nienhuis AW. Methylation-enhanced binding of Sp1 to the stage selector element of the human γ-globin gene promoter may regulate development specificity of expression. Mol Cell Biol 13:3272-3281, 1993.
113. Hornstra IK, Yang TP. Multiple in vivo footprints are specific to the active allele of the X-linked human hypoxanthine phosphoribosyltransferase gene 5′ region: Implications for X chromosome inactivation. Mol Cell Biol 12:5345-5354, 1992.
114. Rincon-Limas DE, Amaya-Manzanares F, Nino-Rosales ML, Yu Y, Yang TP, Patel PI. Ubiquitous and neuronal DNA-binding proteins interact with a negative regulatory element of the human hypoxanthine phosphoribosyltransferase gene. Mol Cell Biol 15:6561-6571, 1995.
115. Wolf SF, Jolly DJ, Lunnen KD, Friedmann T, Migeon BR. Methylation of the hypoxanthine phosphoribosyltransferase locus on the human X chromosome: Implications for X-chromosome inactivation. Proc Natl Acad Sci USA 81:2806-2810, 1984.
116. Yen P, Patel PI, Chinault AC, Mohandas T, Shapiro LF. Differential methylation of HPRT genes on active and inactive human X chromosome. Proc Natl Acad Sci USA 81:1759-1763, 1984.
117. Lock LF, Takagi N, Martin GR. Methylation of the HPRT gene on the inactive X occurs after chromosome inactivation. Cell 48:39-46, 1987.
118. Singer-Sam J, Grant M, LeBon JM, Okuyama K, Chapman V, Monk M, Riggs AD. Use of a HpaII-polymerase chain reaction assay to study DNA methylation in the PGK-1 CpG island of mouse embryos at the time of X-chromosome inactivation. Mol Cell Biol 10:4987-4989, 1990.
119. Grant M, Zuccotti M, Monk M. Methylation of CpG sites of two X-linked genes coincides with X-inactivation in the female mouse embryo but not in the germ line. Nature Genet 2:161-166, 1992.
120. Monk M. The X chromosome in development in mouse and man. J Inherit Metab Dis 15:499-513, 1992.
121. Ackerman SL, Minden AG, Yeung CY. The minimal self-sufficient element in a murine G + C-rich promoter is a large element with imperfect dyad symmetry. Proc Natl Acad Sci USA 90:11865-11869, 1993.
122. Reid LH, Gregg RG, Smithies O, Koller BH. Regulatory elements in the introns of the human HPRT gene are necessary for its expression in embryonic stem cells. Proc Natl Acad Sci USA 87:4299-4303, 1990.
123. Rincon-Limas D, Krueger D, Patel Pl. Functional characterization of the human hypoxanthine phosphoribosyltransferase gene promoter. Evidence for a negative regulatory element. Mol Cell Biol 11:4157-4164, 1991.
124. Johnson P, Friedmann T. Limited bidirectional activity of two housekeeping gene promoters: Human HPRT and PGK. Gene 88:207-213, 1990.
125. Borras T, Peterson CA, Piatigorsky J. Evidence for positive and negative regulation in the promoter of the chicken δ1-crystallin gene. Dev Biol 127:209-219, 1988.
126. Bonnerot C, Grimber G, Briand P, Nicolas JF. Patterns of expression of position-dependent integrated transgenes in mouse embryo. Proc Natl Acad Sci USA 87:6331-6335, 1990.
127. Hooper M, Hardy K, Handyside A, Hunter S, Monk M. HPRT-deficient (Lesch-Nyhan) mouse embryos derived from germline colonization by cultured cells. Nature 326:292-295, 1987.
128. Kuehn MR, Bradley A, Robertson EJ, Evans MJ. A potential animal model for Lesch-Nyhan syndrome through introduction of HPRT mutations into mice. Nature 326:295-298, 1987.
129. Jinnah HA, Gage FH, Friedmann T. Animal models of Lesch-Nyhan syndrome. Br Res Bull 25:467-475, 1990.
130. Keilin J. The biological significance of uric acid and guanine excretion. Biol Rev 34:265-296, 1959.
131. Wu CL, Melton DW. Production of a model for Lesch-Nyhan syndrome in hypoxanthine phosphoribosyltransferase-deficient mice. Nat Genet 3:235-240, 1993.
132. Tanabe Y, Esaki K, Nomura T. Skeletal muscle pathology in X chromosome-linked muscular dystrophy (mdx) mouse. Acta Neuropathol 69:91-95, 1986.
133. Torres LF, Duchen LW. The mutant mdx: Inherited myopathy in the mouse. Morphological studies of nerves, muscles and end-plates. Brain 110:269-299, 1987.
134. Hariharan N, Kelley DE, Perry RP. δ, a transcription factor that binds to downstream elements in several polymerase II promoters, is a functionally versatile zinc finger protein. Proc Natl Acad Sci USA 88:9799-9803, 1991.
135. Riggs KJ, Merrell KT, Wilson G, Calame K. Common factor 1 is a transcriptional activator which binds in the c-myc promoter, the skeletal α-actin promoter, and the immunoglobulin heavy-chain enhancer. Mol Cell Biol 11:1765-1769, 1991.
136. Faisst S, Meyer S. Compilation of vertebrate-encoded transcription factors. Nucleic Acids Res 20:3-26, 1992.
137. Riggs KJ, Saleque S, Wong KK, Merrell KT, Lee JS, Shi Y, Calame K. Yin-Yang 1 activates the c-myc promoter. Mol Cell Biol 13:7487-7495, 1993.
138. Shrivastava A, Calame K. An analysis of genes regulated by the multi-functional transcriptional regulator Yin Yang-1, Nucleic Acids Res 22:5151-5155, 1994.
139. Gualberto A, LePage D, Pons G, Mader SL, Park K, Atchison ML, Walsh K. Functional antagonism between YY1 and the serum response factor. Mol Cell Biol 12:4209-4214, 1992.
140. Lee TC, Shi Y, Schwartz RJ. Displacement of BrdUrd-induced YY1 by serum response factors activates skeletal α-actin transcription in embryonic myoblasts. Proc Natl Acad Sci USA 89:9814-9818, 1992.
141. Oosterwegel MA, van de Wetering ML, Holstege FC, Prosser HM, Owen MJ, Clevers HC. TCF-1, a T cell-specific transcription factor of the HMG box family, interacts with sequence motifs in the TCRβ and TCRδ enhancers. Int Immunol 3:1189-1192, 1991.